Watch the full video on YouTube and awardee portrait to hear more about 2025 Claude Bernard prize recipient, Prof. Andrew Hattersley's lifetime achievements in diabetes research.

In this episode, we explore how a chance encounter led to the discovery of genetic causes of neonatal diabetes, why global collaboration has been central to Exeter's genetic testing service, and how precision medicine is already transforming lives for families worldwide. We also look ahead to what the future may hold for type 2 diabetes.

Join us for an inspiring conversation about breakthroughs in diabetes research and the impact on patients around the globe.

Watch the full lecture and interview on EASDtv. and learn more about the prize recipient.

Explore Prof. Schulman’s groundbreaking research, including the role of ectopic lipid accumulation in insulin resistance, how diacylglycerols impair insulin signalling in liver and muscle, the impact of caloric restriction and incretin therapies in reversing type 2 diabetes, and mitochondrial uncoupling strategies to safely boost fat oxidation.

Discover how these new therapies could help prevent not just diabetes, but also fatty liver disease, heart disease, obesity-related cancers, and Alzheimer’s.

Watch the full video on YouTube to explore how technology is transforming diabetes care.

In this episode, our host Vivienne Parry is joined by Anna Krook (Karolinska Institute), Klemen Dovč (Ljubljana University Medical Centre), Peter Gillard (University Hospital Leuven), and Julia Mader (University of Graz) to discuss:

Learn more about our speakers and their work:

Watch the full video on YouTube to learn how pre-diabetes remission could reshape diabetes care and prevention strategies globally. In this episode, Dr Andreas Birkenfeld (Germany) and Dr. Viswanathan Mohan (India) join Vivienne Parry to discuss:

Learn more about our speakers and their work:

In this episode, diabetes advocates Bastian Hauck, Renza Scibilia and Christian Collin join Vivienne Parry to discuss recent advances in diabetes prevention, screening, and therapeutics - from GLP-1 drugs to innovative community-driven screening strategies. But as science accelerates, can our health systems and societies keep up?

The conversation covers:

Watch the full debate to hear two leading experts tackle one of the most talked-about questions in obesity care. In this episode, Prof. Francesco Rubino (King’s College London) and Dr. Louis Aronne (Cornell Medical College) join Vivienne Parry to debate whether next-generation medications will eventually make obesity surgery obsolete.

The conversation covers:

For deeper insights into incretin science, clinical outcomes, and next-generation therapies, learn more about our expert speakers:

Watch the full video on YouTube to learn how collaborations between academia and pharma are driving progress in diabetes care. In this episode, Dr. Melissa Thomas (Eli, Lilly & Company), Dr. Elizabeth Niemoller (Sanofi) and Prof. Dr. Michele Solimena (Helmholtz Zentrum München & Technical University of Dresden) join Vivienne Parry to unpack the power of partnerships.

The conversation covers:

Listen now for a behind-the-scenes look at the partnerships shaping the future of diabetes care. Visit our speakers’ profiles to learn about their work:

Watch the full video on YouTube to join experts Prof. Raphael Scharfmann (INSERM, France) and Valeria Sordi (San Raffaele Diabetes Research Institute, Italy) as they explore the future of beta cell replacement therapies in diabetes.

They discuss the progress made in generating stem cell–derived beta cells, how insights from developmental biology have shaped clinical protocols, and the latest updates from ongoing clinical trials and translational research. They also examine the key challenges still facing the field, including immune rejection, long-term cell survival, and the complexities of scaling up production for widespread clinical use.

Learn more about our expert speakers and their work:

Learn how diabetes technology is transforming inpatient and pregnancy care in the most recent episode of Diabetes Insights: Breakthroughs and Innovators podcast.

Today, Prof. Hood Thabit and Prof. Helen Murphy discuss how CGM and digital tools are changing clinical practice - from labour wards to emergency admissions - and the need for more integrated care systems, especially for gestational and type 2 diabetes.

Listen for insights on:

Learn more about our speakers:

Delve into the evolving story of GIP-based therapies and their role in type 2 diabetes care. In this episode, our expert guests explore how dual and triple agonists like tirzepatide are reshaping obesity and metabolic control, and why GIP is gaining renewed attention in diabetes pharmacology.

You can also explore each speakers' profiles as well as watch each speaker’s Lecturesession from the EASD Annual Meeting 2024 for deeper insights into incretin science, clinical outcomes, and next-generation therapies: